118 related articles for article (PubMed ID: 11361893)
1. Combination suppresses HIV RNA within the central nervous system.
AIDS Patient Care STDS; 1998 Jan; 12(1):65. PubMed ID: 11361893
[No Abstract] [Full Text] [Related]
2. Combination study of Invirase and Norvir starting.
AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633
[No Abstract] [Full Text] [Related]
3. Ritonavir and saquinavir combination: 12-week data at ICAAC.
James JS
AIDS Treat News; 1996 Oct; (No 256):3. PubMed ID: 11363880
[TBL] [Abstract][Full Text] [Related]
4. The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin.
Losso MH; Lourtau LD; Toibaro JJ; Saenz C; González C
Antivir Ther; 2004 Dec; 9(6):1031-3. PubMed ID: 15651762
[No Abstract] [Full Text] [Related]
5. [Ritonavir/Saqinavir: dual protease inhibitor combination. Salvage therapy].
MMW Fortschr Med; 2000; 142(3 Suppl):41. PubMed ID: 11012293
[No Abstract] [Full Text] [Related]
6. Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir.
Ananworanich J; Gayet-Ageron A; Ruxrungtham K; Chetchotisakd P; Prasithsirikul W; Kiertiburanakul S; Munsakul W; Raksakulkarn P; Tansuphasawadikul S; LeBraz M; Jupimai T; Ubolyam S; Schutz M; Hirschel B;
Antivir Ther; 2008; 13(3):375-80. PubMed ID: 18572750
[TBL] [Abstract][Full Text] [Related]
7. Searching for the right dose of ritonavir-saquinavir.
TreatmentUpdate; 2001 Sep; 13(5):3. PubMed ID: 11768860
[No Abstract] [Full Text] [Related]
8. Boosted saquinavir approved.
AIDS Patient Care STDS; 2004 Mar; 18(3):183. PubMed ID: 15112642
[No Abstract] [Full Text] [Related]
9. Combo approved for HIV treatment.
Nurse Pract; 2004 Mar; 29(3):40. PubMed ID: 15052701
[No Abstract] [Full Text] [Related]
10. FDA notifications. Potential serious effect of combination saquinavir-ritonavir.
AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774
[No Abstract] [Full Text] [Related]
11. Protease inhibitor combination.
AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361664
[No Abstract] [Full Text] [Related]
12. Saquinavir/low-dose ritonavir: its use in HIV infection.
Johnson M; Peters B
AIDS Rev; 2003; 5(1):44-51. PubMed ID: 12875107
[TBL] [Abstract][Full Text] [Related]
13. Combined protease results continue to hold up.
McGuire S
Posit Aware; 1997; 8(1):15. PubMed ID: 11364089
[TBL] [Abstract][Full Text] [Related]
14. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ
J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990
[TBL] [Abstract][Full Text] [Related]
15. Saquinavir plus ritonavir open-label study recruiting.
AIDS Patient Care STDS; 1996 Oct; 10(5):308. PubMed ID: 11361524
[No Abstract] [Full Text] [Related]
16. Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.
Nieuwkerk P; Gisolf E; Sprangers M; Danner S;
Antivir Ther; 2001 Jun; 6(2):97-103. PubMed ID: 11491422
[TBL] [Abstract][Full Text] [Related]
17. [HIV: to administer protease inhibitors early].
Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916
[No Abstract] [Full Text] [Related]
18. A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.
Kirk O; Lundgren JD; Pedersen C; Mathiesen LR; Nielsen H; Katzenstein TL; Obel N; Gerstoft J
Antivir Ther; 2003 Dec; 8(6):595-602. PubMed ID: 14760893
[TBL] [Abstract][Full Text] [Related]
19. The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy.
Staszewski S; Babacan E; Stephan C; Haberl A; Carlebach A; Gute P; Klauke S; Hermschulte Y; Stuermer M; Dauer B;
J Antimicrob Chemother; 2006 Nov; 58(5):1024-30. PubMed ID: 16956902
[TBL] [Abstract][Full Text] [Related]
20. Saquinavir plus ritonavir reduce viral load by 99.9 percent.
Vazquez E
Posit Aware; 1996; 7(6):8-9. PubMed ID: 11363983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
